1
Oxidative metabolism of lansoprazole by human liver cytochromes P450.
Pichard, Lydiane; Curi-Pedrosa, Rozangela; Bonfils, Claude; Jacqz-Aigrain, Evelyne; Domergue, Jacques; Joyeux,
Henri; Cosme, Jose; Guengerich, F. Peter; Maurel, Patrick.
INSERM U-128, CNRS, Montpellier, Fr.
Molecular Pharmacology
(1995), 47(2), 410-18.
Код: Выделить всё
http://molpharm.aspetjournals.org/content/47/2/410.abstract
Determination of lansoprazole and five metabolites in plasma by high-performance liquid chromatography.
Karol, M. D.; Granneman, G. R.; Alexander, K. Drug Metabolism Department, D4PK, AP13A, Abbott Laboratories, Abbott Park, IL, USA.
Journal of Chromatography, B: Biomedical Applications
(1995), 668(1), 182-6.
Код: Выделить всё
http://dx.doi.org/10.1016/0378-4347(95)00068-T
High-performance liquid chromatographic determination of lansoprazole and its metabolites in human serum and urine.
Aoki, Isamu; Okumura, Minoru; Yashiki, Takatsuka. Takeda Anal. Res. Lab., Ltd., Osaka, Japan.
Journal of Chromatography, Biomedical Applications
(1991), 571(1-2), 283-90.
Код: Выделить всё
http://dx.doi.org/10.1016/0378-4347(91)80457-N
Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole.
Miura, M.; Kagaya, H.; Tada, H.; Uno, T.; Yasui-Furukori, N.; Tateishi, T.; Suzuki, T. Department of
Pharmacy, Akita University Hospital, Akita, Japan.
Xenobiotica
(2006), 36(1), 95-102.
Код: Выделить всё
http://dx.doi.org/10.1080/00498250500485065
Influence of cytochrome P450 (CYP) 3A5 polymorphisms on the pharmacokinetics of lansoprazole enantiomers in CYP2C19 extensive metabolizer renal transplant recipients.
Miura, Masatomo; Inoue, Kazuyuki; Satoh, Shigeru; Itoh, Yoshihiko; Kagaya, Hideaki; Tada, Hitoshi; Tanaka, Yorihisa; Habuchi, Tomonori; Suzuki, Toshio. Department of Pharmacy, Akita University Hospital, Akita,
Japan.
Clinical Drug Investigation
(2007), 27(4), 251-258.
Код: Выделить всё
http://adisonline.com/druginvestigation/pages/articleviewer.aspx?year=2007&issue=27040&article=00004&type=abstract